Adoptive Immunotherapy beyond CAR T-Cells

Adoptive Immunotherapy beyond CAR T-Cells

Adoptive cell immunotherapy (ACT) is a vibrant field of cancer treatment that began progressive development in the 1980s. One of the most prominent and promising examples is chimeric antigen receptor (CAR) T-cell immunotherapy for the treatment of B-cell hematologic malignancies. Despite success in...

Full description

Bibliographic Details
Main Authors:	Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, Aygul Valiullina, Alexey Petukhov, Aygul Rakhmatullina, Regina Miftakhova, Michael Fainshtein, Albert Rizvanov, Emil Bulatov
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cancers
Subjects:	chimeric antigen receptor CAR T-cell CAR NK-cell transgeneic TCR TIL neoantigen
Online Access:	https://www.mdpi.com/2072-6694/13/4/743

Similar Items

Knowns and Unknowns about CAR-T Cell Dysfunction
by: Aleksei Titov, et al.
Published: (2022-02-01)

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
by: Aleksei Titov, et al.
Published: (2020-01-01)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
by: Ekaterina Zmievskaya, et al.
Published: (2021-01-01)

Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
by: Irina Ganeeva, et al.
Published: (2022-12-01)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
by: Zhidong Wang, et al.
Published: (2020-03-01)

Evaluation of CAR-T cell cytotoxicity against a prostate carcinoma model
by: A.Kh. Valiullina, et al.
Published: (2022-06-01)

Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by: Vitaly Chasov, et al.
Published: (2024-02-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

CAR-NK as a Rapidly Developed and Efficient Immunotherapeutic Strategy against Cancer
by: Marta Włodarczyk, et al.
Published: (2022-12-01)

Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
by: Katharina Eva Ruppel, et al.
Published: (2022-03-01)

CAR-T: What Is Next?
by: Yi-Ju Chen, et al.
Published: (2023-01-01)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
by: Sergey Kulemzin, et al.
Published: (2021-11-01)

CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings
by: Zeljko Todorovic, et al.
Published: (2022-05-01)

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
by: Adrien Krug, et al.
Published: (2021-12-01)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
by: Ali Keshavarz, et al.
Published: (2022-09-01)

The role of MSCs and CAR-MSCs in cellular immunotherapy
by: Lun Yan, et al.
Published: (2023-08-01)

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
by: Xiaoying Chen, et al.
Published: (2024-04-01)

Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
by: Jesús Fuentes-Antrás, et al.
Published: (2020-10-01)

Adoptivna celična terapija in limfociti T z izraženimi himernimi antigenskimi receptorji
by: Uroš Rajčević
Published: (2020-09-01)

Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
by: Aigul Kh. Valiullina, et al.
Published: (2023-02-01)

A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia
by: Ilias Christodoulou, et al.
Published: (2023-06-01)

Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
by: Carlos Moreno, et al.
Published: (2022-06-01)

Adoptive T cell therapy for solid tumors: current landscape and future challenges
by: Víctor Albarrán, et al.
Published: (2024-03-01)

Solid tumours: Building bridges to CAR‐T success
by: John Maher
Published: (2023-04-01)

Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells
by: Michael Hiltensperger, et al.
Published: (2023-03-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar
by: Bella Guerrouahen, et al.
Published: (2021-01-01)

T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
by: Michael D. Crowther, et al.
Published: (2020-06-01)

Strategies for enhancing CAR T cell expansion and persistence in HIV infection
by: Frederik Holm Rothemejer, et al.
Published: (2023-08-01)

Outsmarting trogocytosis to boost CAR NK/T cell therapy
by: Faezeh Ramezani, et al.
Published: (2023-11-01)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
by: Frederick L. Locke, et al.
Published: (2017-07-01)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
by: Zeynep Sena Karahan, et al.
Published: (2023-03-01)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
by: Jie Yu, et al.
Published: (2021-05-01)

T cell immunotherapy for cervical cancer: challenges and opportunities
by: Lingfeng Yu, et al.
Published: (2023-04-01)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
by: Elisaveta Voynova, et al.
Published: (2021-10-01)

Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
by: Andrea Aran, et al.
Published: (2022-03-01)

CAR-NK Cells in the Treatment of Solid Tumors
by: Ewa Wrona, et al.
Published: (2021-05-01)

Development of CAR T Cell Therapy in Children—A Comprehensive Overview
by: Michael Boettcher, et al.
Published: (2022-04-01)